TENET HEALTHCARE CORP's ticker is THC and the CUSIP is 88033G407. A total of 262 filers reported holding TENET HEALTHCARE CORP in Q4 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
About TENET HEALTHCARE CORP
Tenet Healthcare Corp is a leading healthcare services company that operates hospitals, outpatient centers, and other healthcare facilities across the United States. With a focus on providing high-quality care to patients, Tenet Healthcare has become a trusted name in the healthcare industry.
One of the key strengths of Tenet Healthcare is its commitment to innovation. The company has invested heavily in technology and research to improve patient outcomes and enhance the overall healthcare experience. This has led to the development of new treatments and therapies that have helped countless patients recover from illness and injury.
Another strength of Tenet Healthcare is its talented team of healthcare professionals. The company employs thousands of doctors, nurses, and other healthcare workers who are dedicated to providing the best possible care to patients. This commitment to excellence has earned Tenet Healthcare a reputation as one of the top healthcare providers in the country.
Despite the challenges posed by the COVID-19 pandemic, Tenet Healthcare has continued to provide essential healthcare services to patients across the United States. The company has implemented strict safety protocols to protect patients and staff, and has worked tirelessly to ensure that everyone who needs medical care can receive it.
Overall, Tenet Healthcare Corp is a company that is dedicated to improving the health and wellbeing of people across the United States. With its focus on innovation, commitment to excellence, and talented team of healthcare professionals, Tenet Healthcare is well-positioned to continue providing high-quality care to patients for years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $571,290 | -84.2% | 6,646 | -85.0% | 0.02% | -59.2% |
| Q4 2021 | $3,613,557 | +19.8% | 44,235 | -2.5% | 0.05% | +11.4% |
| Q3 2021 | $3,015,379 | -4.2% | 45,385 | -3.4% | 0.04% | 0.0% |
| Q2 2021 | $3,148,195 | +31.3% | 46,995 | +1.9% | 0.04% | +22.2% |
| Q1 2021 | $2,397,512 | +30.2% | 46,106 | +0.0% | 0.04% | +28.6% |
| Q4 2020 | $1,840,973 | +54.1% | 46,105 | -5.4% | 0.03% | +33.3% |
| Q3 2020 | $1,194,519 | +31.6% | 48,736 | -2.7% | 0.02% | +31.2% |
| Q2 2020 | $907,365 | +10.4% | 50,103 | -12.2% | 0.02% | -5.9% |
| Q1 2020 | $821,981 | -62.9% | 57,082 | -2.0% | 0.02% | -54.1% |
| Q4 2019 | $2,215,666 | +66.9% | 58,261 | -2.9% | 0.04% | +60.9% |
| Q3 2019 | $1,327,687 | +27.6% | 60,022 | +19.1% | 0.02% | +27.8% |
| Q2 2019 | $1,040,809 | -26.0% | 50,378 | +3.3% | 0.02% | -28.0% |
| Q1 2019 | $1,405,835 | +66.4% | 48,746 | -1.1% | 0.02% | +47.1% |
| Q4 2018 | $844,745 | -38.9% | 49,285 | +1.4% | 0.02% | -32.0% |
| Q3 2018 | $1,383,412 | -99.9% | 48,609 | +0.6% | 0.02% | -3.8% |
| Q2 2018 | $1,621,834,000 | +45.9% | 48,312 | +5.4% | 0.03% | +62.5% |
| Q1 2018 | $1,111,669,000 | +155595.9% | 45,842 | -2.6% | 0.02% | +77.8% |
| Q4 2017 | $714,000 | -66.4% | 47,073 | -63.6% | 0.01% | -30.8% |
| Q3 2017 | $2,124,000 | -15.1% | 129,274 | -0.0% | 0.01% | -23.5% |
| Q2 2017 | $2,501,000 | +81.9% | 129,315 | +66.6% | 0.02% | +70.0% |
| Q1 2017 | $1,375,000 | +19.3% | 77,635 | -0.1% | 0.01% | +25.0% |
| Q4 2016 | $1,153,000 | -34.9% | 77,699 | -0.5% | 0.01% | -38.5% |
| Q3 2016 | $1,770,000 | -33.6% | 78,094 | -19.0% | 0.01% | -35.0% |
| Q2 2016 | $2,664,000 | +63.1% | 96,372 | +70.7% | 0.02% | +53.8% |
| Q1 2016 | $1,633,000 | -7.3% | 56,458 | -2.9% | 0.01% | -7.1% |
| Q4 2015 | $1,761,000 | -18.3% | 58,132 | -0.4% | 0.01% | -12.5% |
| Q3 2015 | $2,155,000 | -37.1% | 58,369 | -1.4% | 0.02% | -33.3% |
| Q2 2015 | $3,425,000 | +18.2% | 59,181 | +1.1% | 0.02% | +14.3% |
| Q1 2015 | $2,898,000 | -3.3% | 58,527 | -1.0% | 0.02% | 0.0% |
| Q4 2014 | $2,996,000 | -15.0% | 59,134 | -0.3% | 0.02% | -16.0% |
| Q3 2014 | $3,523,000 | +24.8% | 59,321 | -1.3% | 0.02% | +25.0% |
| Q2 2014 | $2,822,000 | +5.5% | 60,119 | -3.8% | 0.02% | +5.3% |
| Q1 2014 | $2,675,000 | -2.5% | 62,479 | -4.1% | 0.02% | 0.0% |
| Q4 2013 | $2,744,000 | -2.7% | 65,159 | -4.8% | 0.02% | -13.6% |
| Q3 2013 | $2,819,000 | -12.8% | 68,429 | -2.4% | 0.02% | -15.4% |
| Q2 2013 | $3,232,000 | – | 70,112 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Warlander Asset Management, LP | 607,801 | $17,298,000 | 21.78% |
| CASPIAN CAPITAL LP | 525,000 | $14,942,000 | 19.34% |
| Glenview Capital Management | 17,895,314 | $509,301,000 | 3.24% |
| Alta Fundamental Advisers LLC | 190,500 | $5,422,000 | 3.13% |
| Warlander Asset Management, LP | 81,200 | $2,311,000 | 2.91% |
| Camber Capital Management LP | 1,550,000 | $44,113,000 | 1.89% |
| Nantahala Capital Management | 2,108,403 | $60,005,000 | 1.62% |
| PFM Health Sciences, LP | 3,375,241 | $96,059,000 | 1.41% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 3,929,207 | $111,825,000 | 1.22% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 600,000 | $17,076,000 | 1.22% |